GROWTH AND DEVELOPMENT: Lynne L. LevitskyRecent developments in fetal alcohol spectrum disorderBaker, Joshua J.; Stoler, Joan M.Author Information Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA Correspondence to Joan M. Stoler, MD, Division of Genetics and Genomics, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA. Tel: +1 617 355 8315; fax: +1 617 730 0466; e-mail: firstname.lastname@example.org Current Opinion in Endocrinology & Diabetes and Obesity: February 2020 - Volume 27 - Issue 1 - p 77-81 doi: 10.1097/MED.0000000000000518 Buy Metrics Abstract Purpose of review To highlight research, publications, and medical advancements in fetal alcohol spectrum disorder (FASD) over the past 18 months. Recent findings Prevalence numbers have been updated, allowing for a more accurate account of the societal impact. Further work on diagnostic techniques and the underlying mechanisms will allow us to better understand the pathophysiology of FASD and could translate into treatments for the condition. Continued research on new treatments and interventions is needed to improve the affected individual's health care and quality of life. Measurable outcomes allow us to tangibly measure improvements for individuals and families affected by FASD. Summary The current review highlights recent publications from January 2018 to August 2019 showing continued medical advancement in improving the care for children and families affected by FASD. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.